Relay of Herpes Simplex Virus between Langerhans Cells and Dermal Dendritic Cells in Human Skin

PLoS Pathogens

Volumn 11, Issue 4, 2015, Pages

  Kim, Min ^a,b   Truong, Naomi R ^a,b   James, Virginia ^a   Bosnjak, Lidija ^a   Sandgren, Kerrie J ^a,b   Harman, Andrew N ^a,b   Nasr, Najla ^a,b   Bertram, Kirstie M ^a,b   Olbourne, Norman ^c   Sawleshwarkar, Shailandra ^b,d   McKinnon, Kaylene ^d   Cohen, Ralph C ^e   Cunningham, Anthony L ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Senior Registrar in Plastic and Reconstructive Surgery   (Australia)

^d WESTERN SYDNEY SEXUAL HEALTH CENTRE   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BIOPSY; CASE REPORT; CELL INTERACTION; CELL MIGRATION; CHILD; CONTROLLED STUDY; DENDRITIC CELL; EXPLANT; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; INFANT; LANGERHANS CELL; MALE; NONHUMAN; PREPUCE; CELL MOTION; FLUORESCENCE MICROSCOPY; HERPES SIMPLEX VIRUS 1; PATHOGENICITY; PHYSIOLOGY; SIMPLEXVIRUS; SKIN; VIROLOGY;

HUMAN HERPESVIRUS 1; MURINAE; MUS; SIMPLEXVIRUS;

CELL MOVEMENT; DENDRITIC CELLS; FLOW CYTOMETRY; HERPESVIRUS 1, HUMAN; HUMANS; LANGERHANS CELLS; MICROSCOPY, FLUORESCENCE; SIMPLEXVIRUS; SKIN;

EID: 84928470243     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004812     Document Type: Article

References (40)

1. Banchereau J, Steinman RM, Dendritic cells and the control of immunity. Nature. 1998;392(6673):245–52. 9521319
2. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006;194 Suppl 1:S11–8. 16921466
3. Su SJ, Wu HH, Lin YH, Lin HY, Comparative studies of types 1 and 2 herpes simplex virus infection of cultured normal keratinocytes. J Clin Pathol. 1995;48(1):75–9. 7706526
4. Yoshida Y, Li Z, Kurokawa M, Kawana T, Imakita M, Shiraki K, Growth of herpes simplex virus in epidermal keratinocytes determines cutaneous pathogenicity in mice. J Med Virol. 2005;75(3):421–6. 15648069
5. Puttur FK, Fernandez MA, White R, Roediger B, Cunningham AL, Weninger W, et al. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol. 2010;185(1):477–87. doi: 10.4049/jimmunol.0904106 20519652
6. Koelle DM, Corey L, Recent progress in herpes simplex virus immunobiology and vaccine research. Clin Microbiol Rev. 2003;16(1):96–113. 12525427
7. Ashley R, Mertz GJ, Corey L, Detection of asymptomatic herpes simplex virus infections after vaccination. J Virol. 1987;61(2):264–8. 3806788
8. Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK, Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med. 1981;305(6):315–9. 6264300
9. Harrison CJ, Miller RL, Bernstein DI, Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs. Antimicrob Agents Chemother. 1994;38(9):2059–64. 7811019
10. Manickan E, Rouse BT, Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J Virol. 1995;69(12):8178–9. 7494346
11. Cunningham AL, Turner RR, Miller AC, Para MF, Merigan TC, Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest. 1985;75(1):226–33. 3880773
12. Koelle DM, Liu Z, McClurkan CM, Topp MS, Riddell SR, Pamer EG, et al. Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest. 2002;110(4):537–48. 12189248
13. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature. 2011;477(7363):216–9. doi: 10.1038/nature10339 21841802
14. Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, et al. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med. 2007;204(3):595–603. 17325200
15. Sprecher E, Becker Y, Skin Langerhans cells play an essential role in the defense against HSV-1 infection. Arch Virol. 1986;91(3–4):341–9. 3778212
16. Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med. 2003;197(2):153–62. 12538655
17. Bachem A, Guttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med. 2010;207(6):1273–81. doi: 10.1084/jem.20100348 20479115
18. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, Caminschi I, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488–95. doi: 10.1038/ni.1724 19349986
19. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science. 2003;301(5641):1925–8. 14512632
20. Poulin LF, Salio M, Griessinger E, Anjos-Afonso F, Craciun L, Chen JL, et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med. 2010;207(6):1261–71. doi: 10.1084/jem.20092618 20479117
21. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity. 2012;37(1):60–73. doi: 10.1016/j.immuni.2012.04.012 22795876
22. Schlitzer A, Ginhoux F, Organization of the mouse and human DC network. Curr Opin Immunol. 2014;26:90–9. doi: 10.1016/j.coi.2013.11.002 24556405
23. Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, Klekotka PA, et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med. 2010;207(4):823–36. doi: 10.1084/jem.20091627 20351058
24. Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med. 2009;206(13):3115–30. doi: 10.1084/jem.20091756 20008528
25. Segura E, Durand M, Amigorena S, Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J Exp Med. 2013;210(5):1035–47. doi: 10.1084/jem.20121103 23569327
26. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol. 2002;168(5):2118–26. 11859097
27. McGovern N, Schlitzer A, Gunawan M, Jardine L, Shin A, Poyner E, et al. Human Dermal CD14(+) Cells Are a Transient Population of Monocyte-Derived Macrophages. Immunity. 2014;41(3):465–77. doi: 10.1016/j.immuni.2014.08.006 25200712
28. Saksena MM, Wakisaka H, Tijono B, Boadle RA, Rixon F, Takahashi H, et al. Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. J Virol. 2006;80(7):3592–606. 16537627
29. Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, Jackson DC, et al. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. J Immunol. 2012;188(9):4158–70. doi: 10.4049/jimmunol.1103450 22467654
30. Nasr N, Lai J, Botting RA, Mercier SK, Harman AN, Kim M, et al. Inhibition of Two Temporal Phases of HIV-1 Transfer from Primary Langerhans Cells to T Cells: The Role of Langerin. J Immunol. 2014;193(5):2554–64. doi: 10.4049/jimmunol.1400630 25070850
31. Fontaine-Rodriguez EC, Knipe DM, Herpes simplex virus ICP27 increases translation of a subset of viral late mRNAs. J Virol. 2008;82(7):3538–45. doi: 10.1128/JVI.02395-07 18216091
32. O'Toole EA, Extracellular matrix and keratinocyte migration. Clin Exp Dermatol. 2001;26(6):525–30. 11678882
33. Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol. 2005;175(7):4662–8. 16177113
34. Eidsmo L, Allan R, Caminschi I, van Rooijen N, Heath WR, Carbone FR, Differential migration of epidermal and dermal dendritic cells during skin infection. J Immunol. 2009;182(5):3165–72. doi: 10.4049/jimmunol.0802950 19234214
35. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL, Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol. 2005;174(4):2220–7. 15699155
36. Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB, Innate and adaptive immune response to apoptotic cells. J Autoimmun. 2007;29(4):303–9. 17888627
37. Huysamen C, Willment JA, Dennehy KM, Brown GD, CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem. 2008;283(24):16693–701. doi: 10.1074/jbc.M709923200 18408006
38. Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood. 2008;112(8):3264–73. doi: 10.1182/blood-2008-05-155176 18669894
39. Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity. 2012;36(4):646–57. doi: 10.1016/j.immuni.2012.03.009 22483802
40. Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol. 2013;190(1):66–79. doi: 10.4049/jimmunol.1200779 23183897